- If you are wondering whether Amgen’s current share price lines up with its underlying value, you are not alone. This article will walk through what that might look like using several valuation tools.
- Amgen recently closed at US$374.75, with returns of 1.5% over 7 days, 8.7% over 30 days, 14.4% year to date, 27.6% over 1 year, 76.2% over 3 years and 94.9% over 5 years. This gives investors plenty to think about in terms of changing risk and return expectations.
- Recent coverage on Amgen has focused on its position in large cap pharmaceuticals and biotech, as well as ongoing attention to its product portfolio and pipeline. All of this helps frame how investors are reacting to the stock. This broader context is important when you weigh…
Ethereum’s Vitalik Buterin offers new blueprint for crypto security
February 23, 2026
